Jill Biden says the White House medical team failed to catch her husband's prostate cancer while he served as president, a lapse she called "shocking" in a new interview set to air this weekend on CBS News.
The former first lady told CBS interviewer Rita Braver that despite receiving what she considered top-tier medical attention in the White House, the cancer went undetected. Joe Biden revealed his diagnosis publicly last year, disclosing an aggressive form of prostate cancer with a Gleason score of 9, one of the most dangerous classifications, that had already spread to his bones.
The question that hangs over the Biden presidency now is not just political. It is medical: How did the most closely monitored patient in America walk out of the White House with an advanced, metastatic cancer that experts believe he likely carried for years?
In a preview clip released Friday, Jill Biden addressed the missed diagnosis directly:
"Well, you know, the doctor said that according to the American Urological Association, that men over 70 don't need a PSA, a blood test, anymore because it's a slow-growing cancer."
She followed that with a blunter assessment of the outcome.
"I do feel we had amazing care in the White House, but somehow that was missed."
The PSA test, a simple blood draw, is the standard screening tool for prostate cancer. The American Urological Association's guidelines suggest that routine screening may not be necessary for men over 70, in part because many prostate cancers grow slowly and may never become life-threatening. But Biden's cancer was not slow-growing. His Gleason 9 score places it among the most aggressive forms of the disease.
That distinction matters. The same guideline that White House physicians apparently relied on to skip screening was never designed to cover a cancer this dangerous. And the former president reportedly had urinary symptoms before his diagnosis, the kind of red flag that, in most clinical settings, would trigger further investigation regardless of age-based screening protocols.
Jill Biden is not alone in questioning how the cancer slipped through. Oncologist Ezekiel Emanuel, as reported by the Washington Examiner, offered a pointed assessment:
"He probably had it at the start of his presidency, in 2021... And it is a little surprising to many of us oncologists that he wasn't diagnosed earlier. Either they didn't test for it or they did test for it, they didn't report it, and we didn't get the information as a public."
That framing, either the test was skipped or the results were concealed, presents two uncomfortable possibilities, neither of which reflects well on the White House medical operation during Biden's term. The former president had access to the most comprehensive medical care available to any American. If the screening was omitted based on a guideline designed for routine, low-risk patients, that was a clinical judgment call. If it was performed and the results withheld, the implications are far more serious.
No White House physician has been publicly named in connection with the decision. The identity of the doctor Jill Biden referenced remains unclear.
Biden completed five weeks of radiation therapy at Penn Medicine Radiation Oncology in Philadelphia, where family members gathered as he rang a celebratory bell to mark the milestone. He has also undergone hormone treatment.
His office released a statement describing the cancer as "hormone-sensitive," which allows for management. But Dr. Matthew Smith of Massachusetts General Brigham Cancer Center offered a more sobering summary of the medical reality: the cancer is "very treatable, but not curable." Patients with metastatic prostate cancer typically live four to five years.
That timeline puts the stakes of the missed diagnosis in sharp relief. If the cancer was present as early as 2021, as Emanuel and other oncologists suspect, years of potential early intervention were lost, years during which Biden was not only serving as commander-in-chief but also running for reelection.
The cancer interview is not the only revelation Jill Biden has offered in recent weeks. In a separate clip released earlier by CBS News, she described her reaction to her husband's disastrous performance at the 2024 CNN presidential debate.
"I mean, as I watched it, I thought, 'Oh my god, he's having a stroke.' And it scared me to death."
That debate became the turning point. Democratic leaders called for Biden to step aside. He eventually left the race and endorsed Vice President Kamala Harris, who went on to lose the general election to Donald Trump. The sequence, from the debate collapse to the party's internal revolt to Harris's defeat, remains one of the most consequential political unravelings in modern presidential history.
Jill Biden's admission that she feared a stroke in real time raises its own set of questions about what the Biden inner circle knew, and when, about the former president's physical condition.
The full interview is timed to promote her upcoming memoir, "View from the East Wing," set for release on June 2. The book reportedly covers her perspective on the Biden presidency, the 2024 race, and the events that led to her husband's exit from the campaign.
Jill Biden has framed the memoir as an effort to set the record straight on what happened inside the White House. Whether it answers the harder questions, about what the medical team knew, what the family was told, and what was shared with the public, remains to be seen.
The Biden White House faced persistent scrutiny over the former president's health throughout his term. Concerns about his cognitive sharpness, his physical stamina, and his fitness for office were raised repeatedly by critics and, eventually, by members of his own party. The administration's standard response was to dismiss those concerns as politically motivated.
The cancer diagnosis adds a new layer. It is not a matter of political spin or partisan framing. It is a medical fact: a sitting president had an aggressive, metastatic cancer that went undetected, or at least unannounced, for what may have been years. The same White House that assured the public Biden was fit to serve apparently never ran the blood test that would have caught it.
Jill Biden's own words, "somehow that was missed", are striking for their passivity. She credits the White House with "amazing care" in one breath and acknowledges a potentially life-altering failure in the next. The contradiction sits unresolved, much like the broader question of accountability for Biden's medical oversight.
As her memoir reopens the debate debacle and the internal party dynamics that followed, the cancer timeline adds a dimension that no amount of political memoir-writing can fully smooth over. The public was told one thing about the president's health. The reality, it now appears, was something else entirely.
Newsmax reported on the memoir's revisiting of Biden's 2024 exit, and Biden himself publicly thanked supporters after the diagnosis became public. But gratitude and book tours do not substitute for answers about how the most watched medical patient in America slipped through the cracks.
When the most powerful office in the world can't manage a routine blood test, the problem isn't just medical. It's institutional, and the people who deserve answers are the ones who were asked to trust that everything was fine.